Jean Addington
#107,258
Most Influential Person Now
Canadian psychologist and researcher
Jean Addington's AcademicInfluence.com Rankings
Jean Addingtonpsychology Degrees
Psychology
#2225
World Rank
#2595
Historical Rank
Clinical Psychology
#163
World Rank
#165
Historical Rank
Download Badge
Psychology
Why Is Jean Addington Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jean Addington is a Canadian psychiatrist and professor at the University of Calgary. Her research focus is on psychosis and schizophrenia with the goal of finding predictors and mechanisms for mental illness. She is a Fellow of the Royal Society of Canada.
Jean Addington's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. (2008) (1268)
- The psychosis high-risk state: a comprehensive state-of-the-art review. (2013) (1197)
- A depression rating scale for schizophrenics (1990) (1139)
- Assessing Depression in Schizophrenia: The Calgary Depression Scale (1993) (979)
- Reliability and validity of a depression rating scale for schizophrenics (1991) (621)
- Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. (2006) (541)
- Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program. (2016) (538)
- Facial affect recognition and information processing in schizophrenia and bipolar disorder (1998) (471)
- At clinical high risk for psychosis: outcome for nonconverters. (2011) (432)
- Medication adherence of individuals with a first episode of psychosis (2002) (425)
- NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS CONSORTIUM: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS (2008) (415)
- An Individualized Risk Calculator for Research in Prodromal Psychosis. (2016) (403)
- Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. (2009) (403)
- Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression (2018) (384)
- Neurocognitive and social functioning in schizophrenia. (1999) (377)
- Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. (2016) (350)
- Facial affect recognition: A mediator between cognitive and social functioning in psychosis? (2006) (347)
- Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. (2014) (313)
- International clinical practice guidelines for early psychosis (2005) (300)
- Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study (2000) (287)
- Cognitive functioning and positive and negative symptoms in schizophrenia (1991) (277)
- North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. (2007) (277)
- The psychological well-being of family members of individuals with schizophrenia (2001) (262)
- Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. (2015) (258)
- Specificity of the Calgary Depression Scale for schizophrenics (1994) (247)
- Smoking cessation treatment for patients with schizophrenia. (1998) (243)
- Social functioning in individuals at clinical high risk for psychosis (2008) (237)
- Increased Stress-Induced Dopamine Release in Psychosis (2012) (234)
- The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis I. Study rationale and design (2003) (232)
- Negative symptoms in individuals at clinical high risk of psychosis (2012) (229)
- Risk factors for psychosis: impaired social and role functioning. (2012) (224)
- At risk or not at risk? A meta‐analysis of the prognostic accuracy of psychometric interviews for psychosis prediction (2015) (223)
- A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis (2011) (221)
- North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment (2012) (218)
- A psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale (1996) (208)
- Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study (2013) (207)
- Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome (2003) (204)
- The first episode of psychosis: the experience of relatives (2003) (194)
- Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. (2016) (193)
- The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis II. Baseline characteristics of the “prodromal” sample (2003) (191)
- Neuropsychological status of subjects at high risk for a first episode of psychosis (2004) (184)
- The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis (2015) (181)
- Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project (2014) (180)
- Substance misuse at presentation to an early psychosis program (2004) (180)
- Facial affect recognition in individuals at clinical high risk for psychosis (2008) (177)
- Patterns, predictors and impact of substance use in early psychosis: a longitudinal study (2007) (177)
- Prediction and prevention of psychosis in youth at clinical high risk. (2012) (176)
- Reasons for substance use in schizophrenia (1997) (172)
- Influence of social perception and social knowledge on cognitive and social functioning in early psychosis (2006) (168)
- The course of cognitive functioning in first episode psychosis: Changes over time and impact on outcome (2005) (164)
- North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms (2015) (163)
- Pathways to care: help seeking behaviour in first episode psychosis (2002) (162)
- TREATMENTS (2012) (160)
- The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components. (2015) (159)
- The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. (2014) (141)
- Treatment of substance abusers: single or mixed gender programs? (1997) (140)
- Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. (2014) (135)
- Substance use and cognition in early psychosis. (2003) (133)
- Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. (1993) (124)
- Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization (2018) (123)
- Depression in people with first-episode schizophrenia (1998) (122)
- Recruitment and treatment practices for help-seeking "prodromal" patients. (2007) (122)
- Cognitive functioning in first episode psychosis: initial presentation (2003) (122)
- Multisite reliability of MR-based functional connectivity (2017) (121)
- Effect of substance misuse in early psychosis (1998) (118)
- Attentional vulnerability indicators in schizophrenia and bipolar disorder (1997) (116)
- Three-year outcome of family work in an early psychosis program (2005) (114)
- Readiness to Stop Smoking in Schizophrenia (1997) (113)
- Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. (2002) (112)
- The role of family work in early psychosis (2005) (111)
- Social and cognitive functioning in psychosis (2008) (111)
- The association of insight with psychotic symptoms, depression, and cognition in early psychosis: A 3-year follow-up (2007) (110)
- Symptom Outcome 1 Year after Admission to an Early Psychosis Program (2003) (107)
- Social outcome in early psychosis (2003) (106)
- Patterns of premorbid functioning in first episode psychosis: relationship to 2‐year outcome (2005) (105)
- Duration of untreated psychosis: impact on 2‐year outcome (2002) (105)
- International clinical practice guidelines International clinical practice guidelines (2005) (104)
- Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program. (2016) (103)
- The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. (2015) (102)
- Suicidal behaviour in early psychosis (2004) (102)
- Cognitive functioning in first-episode schizophrenia. (2002) (100)
- Early traumatic experiences in those at clinical high risk for psychosis (2013) (100)
- Factorial structure of the Scale of Prodromal Symptoms (2004) (99)
- Outcome of a first episode of psychosis in adolescence: a 2-year follow-up (2005) (97)
- Whither the attenuated psychosis syndrome? (2012) (97)
- Insight in early psychosis: a 1-year follow-up (2004) (97)
- A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. (2015) (97)
- The association between social anxiety and social functioning in first episode psychosis (2005) (96)
- Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. (2007) (96)
- Attempted suicide and depression in schizophrenia (1992) (95)
- Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders. (2010) (94)
- Duration of Untreated Psychosis in Community Treatment Settings in the United States. (2015) (90)
- Positive and negative symptoms of schizophrenia Their course and relationship over time (1991) (88)
- Substance abuse and cognitive functioning in schizophrenia. (1997) (88)
- Predictors of disengagement from treatment in an early psychosis program (2012) (87)
- Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study. (2015) (87)
- Patterns of premorbid functioning in first-episode psychosis: initial presentation (2003) (87)
- Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North America Double Blind Treatment Study (2008) (86)
- Substance use in clinical high risk for psychosis: a review of the literature (2014) (85)
- Social Functioning in First- and Multiepisode Schizophrenia (2001) (80)
- Comorbid diagnoses for youth at clinical high risk of psychosis (2017) (80)
- Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk (2018) (79)
- Duration of untreated psychosis: impact on 2-year outcome (2004) (78)
- The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms (2017) (76)
- Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis (2014) (76)
- Group treatment for smoking cessation among persons with schizophrenia. (1998) (75)
- Assessment of social judgments and complex mental states in the early phases of psychosis (2008) (75)
- The promise of early intervention (2007) (74)
- Premorbid functional development and conversion to psychosis in clinical high-risk youths (2013) (71)
- Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. (2019) (70)
- Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. (2015) (70)
- Social Cognitive Impairments. (2006) (70)
- Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: A preliminary study (2012) (69)
- Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population (2007) (68)
- Youth at ultra high risk for psychosis: using the Revised Network Episode Model to examine pathways to mental health care (2013) (68)
- Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis (2014) (66)
- The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample (2009) (66)
- Relationship between cognitive and social dysfunction in schizophrenia (1998) (66)
- Impact of an early psychosis program on substance use. (2001) (65)
- Screening tools for clinical high risk for psychosis (2015) (64)
- Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study (2015) (63)
- Anxiety in youth at clinical high risk for psychosis (2017) (62)
- Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. (2015) (61)
- Using the brief core schema scales with individuals at clinical high risk of psychosis. (2009) (60)
- Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis (2018) (59)
- Double-Blind, Placebo-Controlled Comparison of the Efficacy of Sertraline as Treatment for a Major Depressive Episode in Patients With Remitted Schizophrenia (2002) (58)
- Telehealth interventions for schizophrenia-spectrum disorders and clinical high-risk for psychosis individuals: A scoping review (2018) (58)
- Exploring the Neural Correlates of Delusions of Reference (2011) (58)
- Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS) (2014) (58)
- Demographic and clinical correlates of substance use disorders in first episode psychosis (2017) (57)
- Affect recognition in people at clinical high risk of psychosis (2012) (57)
- Gender and affect in schizophrenia. (1996) (57)
- Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis (2018) (57)
- Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort (2016) (56)
- Diagnostic stability over one year in first-episode psychosis (2006) (56)
- Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis (2015) (55)
- Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta‐analysis (2019) (55)
- Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis (2013) (55)
- Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome (2013) (55)
- The role of cognitive functioning in the outcome of those at clinical high risk for developing psychosis (2012) (55)
- Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis (2016) (54)
- Substance misuse and cognitive functioning in early psychosis: A 2 year follow-up (2006) (53)
- Interventions and social functioning in youth at risk of psychosis: A systematic review and meta‐analysis (2018) (52)
- Implementing cognitive-behavioural therapy for first-episode psychosis (2005) (51)
- Theory of mind, emotion recognition and social perception in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort (2015) (50)
- Performance measures for early psychosis treatment services. (2005) (50)
- Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort (2010) (50)
- Rating Depression in Schizophrenia: A Comparison of a Self-Report and an Observer Report Scale (1993) (49)
- Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: Analysis from the North American Prodrome Longitudinal Study (2014) (48)
- Symptom remission in first episode patients (2008) (46)
- Substance use in individuals at clinical high risk of psychosis (2015) (45)
- Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis (2017) (45)
- Impact of trauma on attenuated psychotic symptoms (2012) (45)
- Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis (2012) (44)
- Weight Gain in First-Episode Psychosis (2003) (44)
- Current status specifiers for patients at clinical high risk for psychosis (2014) (43)
- Family intervention in an early psychosis program (2001) (43)
- Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. (2015) (43)
- Family assessment in early psychosis (2007) (43)
- Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis (2014) (42)
- Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis (2019) (41)
- Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high‐risk sample (2015) (41)
- The prodromal stage of psychotic illness: observation, detection or intervention? (2003) (41)
- Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups (2018) (41)
- Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task. (2013) (41)
- Relationship between relapse and hospitalization in first-episode psychosis. (2013) (41)
- Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis (2014) (40)
- Clinical staging for youth at‐risk for serious mental illness (2019) (39)
- Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. (2019) (39)
- Predictors of Transition to Psychosis in Individuals at Clinical High Risk (2019) (39)
- Early detection of psychosis: finding those at clinical high risk (2008) (39)
- Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort (2019) (38)
- The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. (2018) (38)
- Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort (2017) (38)
- Severity of thought disorder predicts psychosis in persons at clinical high-risk (2015) (38)
- The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder. (1995) (36)
- Attribution style as a factor in psychosis and symptom resolution (2008) (36)
- Clinical Practice Early Intervention for Psychosis: The Calgary Early Psychosis Treatment and Prevention Program (2001) (35)
- Theory of mind and social judgments in people at clinical high risk of psychosis (2013) (35)
- Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI‐Based Brain Graphs Across Sites, Sessions, and Paradigms (2019) (35)
- Treating young individuals at clinical high risk for psychosis (2012) (34)
- Resilience in individuals at clinical high risk for psychosis (2016) (33)
- Psychological well-being and mental health recovery in the NIMH RAISE early treatment program (2017) (33)
- Psychotropic medication use in youth at high risk for psychosis: Comparison of baseline data from two research cohorts 1998–2005 and 2008–2011 (2013) (33)
- Using measures of readiness to change in individuals with schizophrenia. (1999) (32)
- Perceived discrimination in those at clinical high risk for psychosis (2014) (32)
- Development and preliminary validation of the First Episode Social Functioning Scale for early psychosis (2014) (32)
- Neurocognitive and social functioning in schizophrenia and other diagnoses (2001) (31)
- Pathways to care for those at clinical high risk of developing psychosis (2013) (30)
- Distractibility and symptoms in schizophrenia. (1997) (30)
- Progression from being at-risk to psychosis: next steps (2020) (30)
- Predictors of a clinical high risk status among individuals with a family history of psychosis (2013) (29)
- Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit (2020) (29)
- Prospective Relationships Between Motivation and Functioning in Recovery After a First Episode of Schizophrenia (2018) (29)
- Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution. (2016) (29)
- North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description (2020) (28)
- Metacognitive functioning in individuals at clinical high risk for psychosis. (2014) (28)
- Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction (2018) (28)
- Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis (2017) (28)
- Youth at-risk for serious mental illness: methods of the PROCAN study (2018) (27)
- Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report (2019) (27)
- Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium (2015) (27)
- Psychosocial Treatments for Schizophrenia (2010) (26)
- Core Schemas in Youth at Clinical High Risk for Psychosis (2015) (26)
- Mentally Retarded Patients on General Hospital Psychiatric Units (1993) (26)
- Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis (2017) (26)
- Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services. (2019) (26)
- Group Treatment for Substance Abuse in Schizophrenia (1998) (26)
- Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium (2019) (25)
- The course of cognitive functioning over six months in individuals at clinical high risk for psychosis (2013) (25)
- Risperidone and tardive dyskinesia: a case report. (1995) (25)
- Exercise practices in individuals at clinical high risk of developing psychosis (2015) (25)
- Using the global functioning social and role scales in a first‐episode sample (2011) (25)
- Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants (2019) (25)
- Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis (2018) (24)
- Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. (2020) (24)
- Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion among Clinically High-Risk Youth Developing Psychotic Disorders (2015) (24)
- 23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium (2017) (24)
- Cognitive insight is associated with cortical thickness in first-episode psychosis (2016) (24)
- The Diagnosis and Assessment of Individuals Prodromal for Schizophrenic Psychosis (2004) (24)
- Cyberbullying in those at clinical high risk for psychosis (2013) (23)
- Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis (2019) (23)
- Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study (2019) (23)
- Digital Trajectories to Care in First-Episode Psychosis. (2018) (23)
- Patterns of premorbid functioning in individuals at clinical high risk of psychosis (2015) (22)
- Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review (2019) (22)
- Functional development in clinical high risk youth: Prediction of schizophrenia versus other psychotic disorders (2014) (22)
- 24.2 NEUROCOGNITIVE PROFILES IN THE PRODROME TO PSYCHOSIS IN NAPLS-1 (2018) (22)
- Stress perception following childhood adversity: Unique associations with adversity type and sex (2019) (21)
- Visual attention and symptoms in schizophrenia: a 1-year follow-up (1998) (21)
- Insights into psychosis risk from leukocyte microRNA expression (2016) (20)
- Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study (2017) (20)
- Meta-cognition is associated with cortical thickness in youth at clinical high risk of psychosis (2015) (19)
- Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort (2018) (19)
- Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis (2019) (19)
- How age and gender predict illness course in a first-episode nonaffective psychosis cohort. (2016) (19)
- Social cognition and negative symptoms in psychosis (2011) (19)
- Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers (2016) (18)
- A pilot study of cognitive insight and structural covariance in first-episode psychosis (2017) (18)
- Early intervention for psychosis: Who refers? (2006) (18)
- Working with people at high risk of developing psychosis : a treatment handbook (2005) (18)
- Professionals' negative expectations of boys from father‐headed single‐parent families: Implications for the training of child‐care professionals (1984) (18)
- Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome (2017) (17)
- Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis (2019) (17)
- Attributional Style and Depression in Schizophrenia (1999) (17)
- Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. (2016) (17)
- Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (2015) (17)
- Cognitive behaviour therapy for schizophrenia (2012) (16)
- The content of attenuated psychotic symptoms in those at clinical high risk for psychosis (2014) (16)
- Confirmatory factor analysis of the quality of life scale and new proposed factor structure for the quality of life scale-revised (2017) (16)
- Three-Year Outcome of Treatment in an Early Psychosis Program (2009) (16)
- Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort (2020) (16)
- Family Work in Early Psychosis (2007) (16)
- Networks of blood proteins in the neuroimmunology of schizophrenia (2018) (16)
- Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study (2020) (16)
- Predictive validity of conversion from the clinical high risk syndrome to frank psychosis (2019) (16)
- Social cognition and functional outcome are separate domains in schizophrenia (2011) (15)
- Mapping structural covariance networks of facial emotion recognition in early psychosis: A pilot study (2017) (15)
- Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results (2003) (15)
- Exercise practices of young people at their first episode of psychosis (2014) (15)
- Weight gain in first-episode psychosis over three years (2006) (14)
- Specificity of the calgary depression scale (1993) (14)
- Methodological and Clinical Challenges in Evaluating Treatment Outcome of Substance-Related Disorders and Comorbidity (1999) (14)
- Attrition rates in trials for adolescents and young adults at clinical high‐risk for psychosis: A systematic review and meta‐analysis (2020) (14)
- Reasons for using substances in adolescents with and without psychosis (2008) (14)
- Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis (2015) (14)
- Personal Beliefs about Experiences in those at Clinical High Risk for Psychosis (2014) (14)
- Demographic correlates of attenuated positive psychotic symptoms (2015) (14)
- Neurocognitive deficits in a transdiagnostic clinical staging model (2018) (14)
- Performance measures for evaluating services for people with a first episode of psychosis (2007) (13)
- Interventions and Transition in Youth at Risk of Psychosis: A Systematic Review and Meta-Analyses. (2020) (13)
- Comparison of Social Problem Solving of Children from Open and Traditional Classrooms; A Two-Year Longitudinal Study. (1984) (13)
- Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis (2014) (13)
- Cognitive and social functioning in schizophrenia (1995) (13)
- Depression Dexamethasone Nonsuppression and Negative Symptoms in Schizophrenia (1990) (13)
- The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis (2016) (13)
- The Role of microRNA Expression in Cortical Development During Conversion to Psychosis (2017) (13)
- Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study (2018) (13)
- Childhood trauma and amygdala nuclei volumes in youth at risk for mental illness. (2020) (13)
- Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome (2020) (12)
- Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. (2018) (12)
- Tobacco use and psychosis risk in persons at clinical high risk (2017) (12)
- Perceptions of parent and child adjustment in divorced families (1985) (12)
- Calgary Depression Scale for Schizophrenia (2011) (12)
- Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis (2019) (12)
- Family functioning in youth at-risk for serious mental illness. (2018) (12)
- Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort (2021) (12)
- The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning (2019) (12)
- Sleep disturbances in youth at‐risk for serious mental illness (2019) (12)
- Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis (2012) (11)
- The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning (2018) (11)
- The Assessment of Depression in Schizophrenia (1989) (11)
- Outcome after discharge from an early psychosis program (2008) (11)
- Perceived Autonomy Support in the NIMH RAISE Early Treatment Program. (2017) (11)
- EARLY DETECTION AND INTERVENTION FOR PSYCHOSIS: PERSPECTIVES FROM NORTH AMERICA. (2008) (11)
- White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis (2021) (10)
- Stability of mismatch negativity event‐related potentials in a multisite study (2020) (10)
- Cognitive behavioral therapy in prodromal psychosis. (2012) (10)
- Faculty Opinions recommendation of The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. (2012) (10)
- The Early Psychosis Screener (EPS): Item development and qualitative validation (2017) (10)
- Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth (2017) (10)
- Changes in symptom content from a clinical high‐risk state to conversion to psychosis (2019) (10)
- Cognitive-Behavioral Therapy for Individuals Recovering from a First Episode of Psychosis (2006) (10)
- Exploration of clinical high-risk dropouts (2017) (10)
- One-Year Stability of Diagnosis in First-Episode Nonaffective Psychosis: Influence of Sex (2006) (10)
- The Violent Content in Attenuated Psychotic Symptoms (2016) (10)
- Negative Symptoms and Functioning in Youth at Risk of Psychosis: A Systematic Review and Meta-analysis (2020) (10)
- Neurocognitive Functioning in Schizophrenia: A Trial of Risperidone versus Haloperidol (1997) (10)
- Treatment possibilities for individuals at clinical high risk of psychosis (2013) (10)
- Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis (2020) (10)
- Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator (2020) (9)
- Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study (2019) (9)
- Duration of the psychosis prodrome (2019) (9)
- Clinical trials during the prodromal stage of schizophrenia. (2005) (9)
- The role of a family history of psychosis for youth at clinical high risk of psychosis (2019) (9)
- Self‐report of family functioning and risk for psychotic disorders in male adolescents with behavioural disturbances (2008) (9)
- Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD (2019) (8)
- Cognitive-behavioral therapy for individuals at high risk of developing psychosis. (2009) (8)
- Cognitive behavioural social skills training: Methods of a randomized controlled trial for youth at risk of psychosis (2021) (8)
- Traumatic brain injury in individuals at clinical high risk for psychosis (2016) (8)
- Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis. (2022) (8)
- Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis (2019) (8)
- Medication Prescription Practices for the Treatment of First Episode Schizophrenia-Spectrum Disorders: Data from the National RAISE-ETP Study (2015) (8)
- Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis (2016) (7)
- Treatment History of Youth At-Risk for Serious Mental Illness (2018) (7)
- Trauma in Youth At-Risk for Serious Mental Illness. (2020) (7)
- An Integrated Treatment Approach to Substance Use in an Early Psychosis Programme (2008) (7)
- Brain changes associated with negative symptoms in clinical high risk for psychosis: A systematic review (2020) (7)
- Social Cognition Early in the Course of the Illness (2013) (7)
- Social and role functioning in youth at risk of serious mental illness (2020) (7)
- Psychosocial treatments for clinical high risk individuals. (2015) (6)
- Sleep Disturbance in Individuals at Clinical High Risk for Psychosis. (2021) (6)
- Neurocognition in first episode schizophrenia: A 2 year follow-up (2000) (6)
- The development of the Content of Attenuated Positive Symptoms Codebook for those at clinical high risk of psychosis (2012) (6)
- Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms (2020) (6)
- Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study (2019) (6)
- Clinical staging for youth at‐risk for serious mental illness: A longitudinal perspective (2020) (6)
- Between-site reliability of startle prepulse inhibition across two early psychosis consortia (2013) (6)
- Aberrant limbic brain structures in young individuals at risk for mental illness (2020) (6)
- Social functioning in first and multi-episode schizophrenia (2000) (6)
- Embracing heterogeneity creates new opportunities for understanding and treating those at clinical-high risk for psychosis (2020) (6)
- Deficits in Auditory Predictive Coding in Individuals With the Psychosis Risk Syndrome: Prediction of Conversion to Psychosis (2020) (5)
- Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study (2021) (5)
- Poster #167 EFFECTS OF COGNITIVE REMEDIATION ON COGNITION IN YOUNG PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS (2012) (5)
- International Early Psychosis Association (2012) (5)
- SEX DIFFERENCES IN SYMPTOM PRESENTATION IN INDIVIDUALS AT RISK FOR PSYCHOSIS (2010) (5)
- Cross-paradigm connectivity: reliability, stability, and utility (2020) (5)
- Olanzapine versus placebo for prodromal symptoms (2003) (5)
- The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis (2018) (5)
- Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. (2020) (4)
- Depression: An actionable outcome for those at clinical high-risk (2020) (4)
- 0469 YOUTH EXPERIENCING FIRST EPISODE PSYCHOSIS: A COMPREHENSIVE EXAMINATION OF PATHWAYS TO MENTAL HEALTH CARE (2006) (4)
- Personality and risk for serious mental illness (2020) (4)
- Insight, Knowledge, and Beliefs about Illness in First-Episode Psychosis (2003) (4)
- 5/Directions for Clinical-Psychosocial Assessment of Depression in the Elderly (1986) (4)
- Advances in early detection, treatment and prevention: Findings from the North American Prodrome Longitudinal Study (2008) (4)
- Pilot aerobic exercise intervention for youth at‐risk for serious mental illness (2020) (4)
- Neurocognitive functioning in first episode schizophrenia (1998) (4)
- The Association Between Neighborhood Poverty and Hippocampal Volume Among Individuals at Clinical High-Risk for Psychosis: The Moderating Role of Social Engagement. (2022) (4)
- Early Psychosis Intervention-Spreading Evidence-based Treatment (EPI-SET): protocol for an effectiveness-implementation study of a structured model of care for psychosis in youth and emerging adults (2020) (4)
- Models of substance use in adolescents with and without psychosis. (2008) (4)
- Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis (2022) (4)
- The Recognition and Management of Early Psychosis: Complete and incomplete recovery from first-episode psychosis (2009) (4)
- Pilot study of cognitive remediation and motivational interviewing in youth at risk of serious mental illness (2018) (4)
- The Prodrome of Schizophrenia (2011) (4)
- F32. DIFFERENCES BETWEEN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS WHO DO NOT TRANSITION TO PSYCHOSIS: THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (NAPLS-2) (2018) (4)
- Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk (2022) (4)
- The associations between migrant status and ethnicity and the identification of individuals at ultra-high risk for psychosis and transition to psychosis: a systematic review (2021) (4)
- S102. COGNITIVE-BEHAVIORAL SOCIAL SKILLS TRAINING IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS: QUANTITATIVE AND QUALITATIVE METHODS: FOR IMPLEMENTATION AND FACILITATOR TRAINING (2019) (4)
- Serum Monitoring of Antipsychotic Drug Levels during Concomitant Administration of Sertraline and Antipsychotic Medication (2006) (4)
- CLINICAL HIGH RISK FOR PSYCHOSIS: THE RISK OF FALSE POSITIVE (2010) (4)
- Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis (2020) (3)
- White Matter Connectivity in Youth at Risk for Serious Mental Illness: A Longitudinal Analysis (2020) (3)
- Negative symptoms: associations with defeatist beliefs, self-efficacy, and maladaptive schemas in youth and young adults at-risk for psychosis (2021) (3)
- Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis (2020) (3)
- 88-2 Smoking cessation treatment in schizophrenia (1997) (3)
- The psychopharmacology of schizophrenia (1993) (3)
- Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study (2021) (3)
- Cognitive behaviour therapy and early intervention (2013) (3)
- Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium (2021) (3)
- SU127. Negative Symptoms in Youth at Clinical High Risk of Psychosis (2017) (3)
- EXPLORING THE NEURAL CORRELATES OF DELUSIONS OF REFERENCE: AN fMRI STUDY (2008) (3)
- Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes. (2022) (3)
- O33. EEG Alpha Event-Related Desynchronization Deficits Predict Conversion to Psychosis in Individuals With the Psychosis Risk Syndrome (2019) (3)
- Bullying and social functioning, schemas, and beliefs among youth at clinical high risk for psychosis (2021) (3)
- USING THE GLOBAL FUNCTIONING SOCIAL AND ROLE SCALES IN A FIRST EPISODE SAMPLE (2010) (3)
- Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety (2017) (3)
- The association between migrant status and transition in an ultra-high risk for psychosis population (2021) (3)
- Development and Usability Testing of SOMO, a Mobile-Based Application to Monitor Social Functioning for Youth at Clinical High-Risk for Psychosis (2020) (3)
- Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis (2022) (3)
- Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm (2020) (2)
- Use of the Self-Esteem Rating Scale—Short Form in a first episode of psychosis sample (2013) (2)
- Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis (2021) (2)
- Family history of psychosis in youth at clinical high risk: A replication study (2022) (2)
- T29. TREATMENT AND GLOBAL FUNCTIONING IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2019) (2)
- Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis. (2021) (2)
- White matter microstructure in youth at risk for serious mental illness: A comparative analysis (2021) (2)
- Binocular depth perception in individuals at clinical high risk for psychosis: no evidence of dysfunction. (2014) (2)
- O3.2. BRAIN HYPERACTIVATION DURING MEMORY RETRIEVAL PRECEDES AND PREDICTS CONVERSION TO PSYCHOSIS IN INDIVIDUALS AT CLINICAL HIGH RISK (2018) (2)
- Substance use in youth at‐risk for serious mental illness (2020) (2)
- Poster #183 PREDICTORS OF DISENGAGEMENT FROM TREATMENT IN AN EARLY PSYCHOSIS PROGRAM (2012) (2)
- Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review (2021) (2)
- F202. Atypical P300 Amplitude Differentiates Conversion Patterns in Psychosis Prodrome When Autism Spectrum Disorder is Comorbid (2018) (2)
- 4th International Conference on Early Psychosis: ‘Translating the Evidence’ (2005) (2)
- The Recognition and Management of Early Psychosis: At-risk mental state: management (2009) (2)
- NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS (2008) (2)
- Increased Stress-Induced Dopamine Release in (2012) (2)
- 209. Risk of Violence in Attenuated Psychosis Symptoms Syndrome and its Relationship With Symptomology. (2017) (2)
- LooseLeaf, a Mobile-Based Application to Monitor Cannabis Use and Cannabis-Related Experiences for Youth at Clinical High-Risk for Psychosis: Development and User Acceptance Testing (2020) (2)
- STRESS-INDUCED DOPAMINE RELEASE IN SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS AND IN ANTIPSYCHOTIC NAIVE PATIENTS WITH PSYCHOSIS: A [ 11 C]-(+)-PHNO PET STUDY (2010) (2)
- Poster #M79 EFFECTS OF COGNITIVE REMEDIATION ON COGNITION IN YOUNG PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS (2014) (2)
- Original Article Performance measures for evaluating services for people with a first episode of psychosis (2007) (2)
- Functional imaging in youth at risk for transdiagnostic serious mental illness: Initial results from the PROCAN study (2020) (2)
- T104. PSYCHOTIC-LIKE EXPERIENCES AND PROBLEMATIC GAMING BEHAVIOR IN ONLINE GAME FORUMS (2020) (2)
- Mismatch Negativity Abnormalities Are Associated with Poorer Functioning in Youth at Clinical High Risk for Psychosis: Evidence from the NAPLS Study (2013) (2)
- Visual attention and positive and negative symptoms of schizophrenia (1993) (2)
- Factor analysis of depression scales in schizophrenia (1995) (1)
- Working with Families Following the Diagnosis of an at Risk Mental State (2008) (1)
- Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed (2005) (1)
- Neuropsychological status of the first-episode prodrome (2003) (1)
- WC2C ADAPT (ACCESS, DETECTION AND PSYCHOLOGICAL TREATMENTS) (2006) (1)
- S184. MACHINE LEARNING REVEALS DEVIANCE IN NEUROANATOMICAL MATURITY PREDICTIVE OF FUTURE PSYCHOSIS IN YOUTH AT CLINICAL HIGH RISK (2018) (1)
- M100. LOOSELEAF: DEVELOPING A MOBILE-BASED APPLICATION TO MONITOR DAILY CANNABIS USAGE IN YOUTH AT CLINICAL HIGH-RISK OF PSYCHOSIS: APP DEVELOPMENT AND USABILITY TESTING (2020) (1)
- Social outcome in early psychosis: A two year follow-up (2003) (1)
- 20. Metabolic Abnormalities and Omega-3 Fatty Acids in Latinos at Clinical High Risk for Psychosis. (2017) (1)
- Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosis (2023) (1)
- Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis (2021) (1)
- WC8C NAPLS CONSORTIUM: IMPAIRED SOCIAL, SCHOOL, AND WORK FUNCTIONING CHARACTERIZES PRODROMAL INDIVIDUALS PRIOR TO EMERGENCE OF PSYCHOSIS (2006) (1)
- Harmonizing the structured interview for psychosis-risk syndromes (SIPS) and the comprehensive assessment of at-risk mental states (CAARMS): An initial approach. (2023) (1)
- Cognitive Insight in Youth at Clinical High Risk of Psychosis (2015) (1)
- THE PSYCHOSIS HIGH RISK STATE: IS IT VALID? (2014) (1)
- Intravenous tripelennamine abuse in schizophrenia. (1996) (1)
- Greater Prepulse Inhibition Prior to the Onset of Psychosis? Findings from the North American Prodrome Longitudinal Study Consortium (2011) (1)
- A mobile-based app to monitor social functioning among youth at-risk for psychosis: Single-arm feasibility and acceptability study. (2020) (1)
- Anxiety in youth at clinical high-risk for psychosis: A two-year follow-up (2021) (1)
- Cerebello-limbic functional connectivity patterns in youth at clinical high risk for psychosis (2022) (1)
- Gender differences in cognitive functioning and symptoms in schizophrenics (1991) (1)
- Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort (2022) (1)
- P-7-20 The relationship between negative symptoms and depression in schizophrenia (1996) (1)
- THE NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS STUDY: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS (2008) (1)
- Faculty Opinions recommendation of The negative symptoms of schizophrenia: a cognitive perspective. (2012) (1)
- F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER (2018) (1)
- Adapting Evidence-Based Early Psychosis Intervention Services for Virtual Delivery: Protocol for a Pragmatic Mixed Methods Implementation and Evaluation Study (2021) (1)
- Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis (2019) (1)
- Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial. (2022) (1)
- Depression, family interaction and family intervention in adolescents at clinical‐high risk for psychosis (2020) (1)
- SOCIAL COGNITION IN SCHIZOPHRENIA: A QUANTITATIVE REVIEW OF THE LITERATURE (2010) (1)
- The associations between area-level residential instability and gray matter volumes from the North American Prodrome Longitudinal Study (NAPLS) consortium (2022) (1)
- O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT (2020) (1)
- Toward leveraging big data in human functional connectomics: Generalization of brain graphs across scanners, sessions, and paradigms (2017) (1)
- Cognitive-Behavioral Social Skills Training Adapted for Youth at Clinical High Risk for Psychosis. (2022) (1)
- Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort (2022) (1)
- The Canadian Network for Research in Schizophrenia and Psychoses: A Nationally Focused Approach to Psychosis and Schizophrenia Research (2021) (1)
- Cognitive and social functioning in schizophrenia outpatients who abuse substances (1996) (1)
- P583. Morphometric Similarity Network Alterations in Youth at Clinical High Risk for Psychosis (2022) (0)
- 59.4 Networks of Blood Analytes are Collectively Informative of Risk of Conversion to Schizophrenia. (2017) (0)
- TC7A THE IMPACT OF COGNITIVE FUNCTIONING ON OUTCOME (2006) (0)
- Faculty Opinions recommendation of More harm than good: the case against using anti-psychotic drugs to prevent severe mental illness. (2012) (0)
- Identification and Treatment of Youth with Attenuated Psychosis Syndromes: A Canadian Perspective (2019) (0)
- Course, correlates and predictors of depression in schizophrenia (1996) (0)
- Poster #143 AT RISK FOR PSYCHOSIS: THE ROLE OF COGNITION (2012) (0)
- F61. TRIVIAL TRANSITIONS? SIPS-DEFINED CONVERSIONS TO PSYCHOSIS: ONE YEAR OUTCOME (2019) (0)
- The Correlates of Sleep Disturbance in Symptomatic Youth (2019) (0)
- The prevention of a first-epidsode of psychosis (2013) (0)
- Poster #T38 PREDICTION OF SYMPTOM OUTCOME IN CLINICAL HIGH RISK SUBJECTS USING THE ACOUSTIC STARTLE PARADIGM (2014) (0)
- WC8D THE DEVELOPMENT OF THE NAPLS DATASET AND BASELINE SAMPLE CHARACTERISTICS (2006) (0)
- SOCIAL COGNITION AND FUNCTIONAL OUTCOME AS SEPARATE DOMAINS IN SCHIZOPHRENIA (2010) (0)
- DELUSIONS OF REFERENCE AND ABNORMALITIES IN SOCIAL COGNITION (2009) (0)
- WC8B NEUROCOGNITIVE FUNCTIONING IN THE PRODROME TO PSYCHOSIS FROM THE NAPLS COLLABORATION (2006) (0)
- Heterogeneity of Psychosis RiskWithin Individuals at Clinical High Risk AMeta-analytical Stratification (2016) (0)
- Faculty Opinions recommendation of The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. (2012) (0)
- WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS (2006) (0)
- Faculty Opinions recommendation of Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project. (2012) (0)
- Reviewers for The American Journal of Psychiatry. (2017) (0)
- Current Directions in Psychological Science (2010) (0)
- Cognitive Neuropsychiatry Volume 20, 2015, List of Reviewers. (2015) (0)
- Review Article The promise of early intervention (2007) (0)
- Poster #239 FAMILY HISTORY OF PSYCHOSIS, SOCIAL RISK FACTORS AND RISK OF DEVELOPING PSYCHOSIS (2012) (0)
- S21. THE IMPACT OF PERSISTENT NEGATIVE SYMPTOMS ON FUNCTIONING AND DEFEATIST BELIEFS IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS (2019) (0)
- O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (2020) (0)
- F236. Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis (2018) (0)
- 192. Different Age-Related Trajectories of Social Cognition in Youths at Clinical High Risk of Psychosis (2017) (0)
- Metacognition in youth at-risk for psychosis (2019) (0)
- P-22-5 Cognitive functioning in schizophrenia: A trial of risperidone versus haloperidol (1996) (0)
- Japanese Abstract (2020) (0)
- Early psychosis services (2020) (0)
- Longitudinal Trends in Medication Treatment for Youth At-Risk for Serious Mental Illness (2021) (0)
- Faculty Opinions recommendation of Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research. (2012) (0)
- Poster #162 AFFECT RECOGNITION IN PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS (2012) (0)
- F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder (2019) (0)
- schizophrenia-spectrum disorders in a prodromal population Extracting spurious messages from noise and risk of (2012) (0)
- S80. NEUROCOGNITIVE FUNCTIONING IN YOUTH AT RISK OF SERIOUS MENTAL ILLNESS (2018) (0)
- Engagement and the Therapeutic Alliance (2008) (0)
- S0033291718002258jra 1670..1677 (2019) (0)
- University of Birmingham Early intervention in psychosis: keeping faith with evidence-based health care (2010) (0)
- Substance use in youth at genetic and clinical high risk for psychosis (2022) (0)
- T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS (2020) (0)
- Identifying a Treatable Psychosis-Risk Cohort (2013) (0)
- Brain connectomes in youth at risk for serious mental illness: an exploratory analysis (2022) (0)
- PRODROMAL SYMPTOMS: DIFFERENTIAL EFFECTS OF SEX AND FAMILY HISTORY (2010) (0)
- 100. Converging Evidence for Social Functioning Deficits as a Neurodevelopmental Risk Factor in High-Risk Youth (2017) (0)
- O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT (2018) (0)
- S244. CHARACTERIZING OUTCOMES OF CLINICAL HIGH-RISK NON-CONVERTERS USING GROUP-BASED TRAJECTORY MODELING (2018) (0)
- The influence of sex and age at onset in the presentation and course of schizophrenia (2016) (0)
- Duration of untreated psychosis significantly associated with positive symptoms one year after treatment (2004) (0)
- Aerobic exercise and hippocampal change in youth at risk of serious mental illness (2020) (0)
- 248 Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up study (1997) (0)
- Healthy Adolescent Performance on the MATRICS Cognitive Consensus Battery (MCCB): Developmental Data from Two Samples of Volunteers (2017) (0)
- 42. Heterogeneity of Neuropsychological Profiles in the Prodrome to Psychosis: An Examination of the Association Between Cognition and Clinical Outcomes in NAPLS-1 (2017) (0)
- 39.1 DNA METHYLATION OF IMMUNE CELLS IN PERSONS AT CLINICAL HIGH RISK FOR PSYCHOSIS (2018) (0)
- Assessing social functioning in youth at clinical high-risk for psychosis (2021) (0)
- Faculty Opinions recommendation of Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. (2012) (0)
- Social cognition in first episode psychosis (2003) (0)
- 80. Auditory Target Processing Deficits in Individuals at Clinical High Risk for Psychosis (2017) (0)
- M118. Functional Capacity: A New Predictor of Role Functioning in Individuals at Clinical High Risk for Psychosis (2017) (0)
- Reviewers for The American Journal of Psychiatry. (2015) (0)
- Adapting evidence-based early psychosis intervention services for virtual delivery: Protocol for a pragmatic mixed-methods implementation and evaluation study (Preprint) (2021) (0)
- Diagnoses at the first psychotic episode and cognitive functioning (2002) (0)
- Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High-Risk for Psychosis and Healthy Youths. (2021) (0)
- EXAGGERATED DOPAMINE RELEASE IN IMMIGRANTS DURING SOCIAL STRESS: A RISK MECHANISM FOR PSYCHOSIS (2014) (0)
- FC4C FAMILY WORK IN A FIRST EPISODE PROGRAM: OUTCOME AT THREE YEARS (2006) (0)
- Faculty Opinions recommendation of Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. (2012) (0)
- Indicated prevention in psychosis risk—psychological approaches (2020) (0)
- Development and Usability Testing of SOMO, a Mo-bile-Based Application to Monitor Social Functio ning for Youth at Clinical High-Risk for Psychosis (2020) (0)
- Faculty Opinions recommendation of Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses. (2012) (0)
- T13. THE ASSOCIATION BETWEEN CHILDHOOD TRAUMA AND INFLAMMATION IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS (2019) (0)
- O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS (2018) (0)
- Implementing cognitive ^ behavioural therapy Implementing cognitive ^ behavioural therapy for first-episode psychosis for first-episode psychosis (2005) (0)
- ATTRIBUTION STYLE IS ASSOCIATED WITH SEVERITY OF PSYCHOTIC SYMPTOMS AND RECOVERY IN PRIMARY PSYCHOTIC DISORDERS (2008) (0)
- Longitudinal outcome of first episode psychosis in adolescence (2002) (0)
- Extracting spurious messages from noise Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders and risk of schizophrenia-spectrum disorders in a prodromal population in a prodromal population (2006) (0)
- Gamma Oscillations and Excitation/Inhibition Imbalance: Parallel Effects of NMDA Receptor Antagonism and the Psychosis Risk Syndrome (2020) (0)
- 0004 EVALUATING EARLY PSYCHOSIS TREATMENT SERVICES WITH PERFORMANCE MEASURES (2006) (0)
- 8. Social Cognition in Those at High Risk of Psychosis (2015) (0)
- RelationshipBetweenRelapseand HospitalizationinFirst-EpisodePsychosis (2013) (0)
- Testing the feasibility of a computerized facial affect recognition training in early psychosis (2017) (0)
- Models of substance use in adolescents experiencing a first episode of psychosis (2003) (0)
- S106. MONITORING SOCIAL FUNCTIONING THROUGH A MOBILE-BASED APPLICATION FOR YOUTH AT-RISK OF PSYCHOSIS: 2-MONTH FEASIBILITY STUDY (2020) (0)
- A mobile-based app to monitor cannabis use among youth at clinical high risk (CHR) for psychosis: Feasibility and acceptability of LooseLeaf (2020) (0)
- Patient-Reported Outcome Measures in Clinical High Risk for Psychosis: A Systematic Review (2023) (0)
- Longitudinal impact of trauma in the North American Prodrome Longitudinal Study‐3 (2022) (0)
- S190. Does Cannabis Use Interact With Neurophysiological Vulnerability in the Early Expression of Psychosis and Conversion Status in Clinical High-Risk (CHR) Individuals? (2019) (0)
- A t C linical H igh R isk for P sychosis: ou tcom e for N onconverters (2011) (0)
- S57. Does the Acquisition of Social Cognitive Skills Over Adolescence Coincide With Neurophysiological Metric of Brain Maturation? A Cross-Sectional Analysis of the NAPLS-II Consortium Sample (2019) (0)
- Reliability and validity of a depression scale for schizophrenics (1991) (0)
- Depression and Suicidality (2012) (0)
- University of Groningen Individualized Prediction of Transition to Psychosis in 1 , 676 Individuals at Clinical High Risk (2019) (0)
- Family‐focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial (2021) (0)
- Family communication and the efficacy of family focused therapy in individuals at clinical high risk for psychosis with comorbid anxiety (2022) (0)
- Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis (2023) (0)
- 2.2 Risk of Violent Behavior in Young Adults at Clinical High Risk for Psychosis From the North American Prodrome Longitudinal Studies Consortium (2022) (0)
- Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis. (2022) (0)
- Hippocampal Connectivity With the Default Mode Network Is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals (2023) (0)
- 352. Resource Utilization and Comorbidity in Clinical High-Risk Individuals in the North American Prodrome Longitudinal Studies (NAPLS) 3 Cohort (2023) (0)
- Title: Linking Choroid Plexus Enlargement with Plasma Analyte and Structural Phenotypes in Clinical High Risk for Psychosis: A Multisite Neuroimaging Study Short Title: Choroid Plexus Enlargement in Clinical High Risk for Psychosis (2022) (0)
- Sampling from different populations: Sociodemographic, clinical, and functional differences between samples of first episode psychosis individuals and clinical high-risk individuals who progressed to psychosis (2023) (0)
- P586. Relation of Regional Cortical Thickness and Surface Area With General Cognitive Abilities in Psychosis-Risk (2022) (0)
- Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium. (2023) (0)
- Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization (2018) (0)
- 315. Disease-Informed Assessment Identifies Robust Brain Correlates of Cognitive Performance in Psychosis and its Prodrome (2023) (0)
- P535. Neighborhood Poverty and Hippocampal Volume Among Individuals at Clinical High Risk for Psychosis: The Moderating Role of Social Engagement (2022) (0)
- 11. The Association Between Ethnic Minority Density During Childhood and Cortical Thickness: The Moderating Role of Social Engagement Among Minority Youth (2023) (0)
- The association between area-level residential instability and gray matter volume changes (2022) (0)
- Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 study (2022) (0)
- Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (2023) (0)
- 133. Dynamic Prediction of Outcomes for Youth at Clinical High-Risk for Psychosis: A Joint Modeling Approach (2023) (0)
- 14. Frequency of Cannabis-Use, Neurocognitive Performance and Functioning in Clinical High-Risk Participants From the NAPLS-3 Cohort: Moderate Use is Associated With Better Performance and Functioning (2023) (0)
- Cross-paradigm connectivity: reliability, stability, and utility (2020) (0)
- Type A behavior and coronary artery disease risk factors in adolescents (1991) (0)
This paper list is powered by the following services:
Other Resources About Jean Addington
What Schools Are Affiliated With Jean Addington?
Jean Addington is affiliated with the following schools:
